Search by Drug Name or NDC

    NDC 00115-2134-01 Pyridostigmine Bromide 30 mg/1 Details

    Pyridostigmine Bromide 30 mg/1

    Pyridostigmine Bromide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals of New York LLC. The primary component is PYRIDOSTIGMINE BROMIDE.

    Product Information

    NDC 00115-2134
    Product ID 0115-2134_83d6b85c-0cd0-467c-90aa-6998f5302559
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Pyridostigmine Bromide
    Proprietary Name Suffix n/a
    Non-Proprietary Name PYRIDOSTIGMINE BROMIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 30
    Active Ingredient Units mg/1
    Substance Name PYRIDOSTIGMINE BROMIDE
    Labeler Name Amneal Pharmaceuticals of New York LLC
    Pharmaceutical Class Cholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA040502
    Listing Certified Through 2024-12-31

    Package

    NDC 00115-2134-01 (00115213401)

    NDC Package Code 0115-2134-01
    Billing NDC 00115213401
    Package 21 TABLET in 1 BOTTLE (0115-2134-01)
    Marketing Start Date 2022-08-08
    NDC Exclude Flag N
    Pricing Information N/A
    << 00115-2011-02 00115-2142-02 >>

    Contents